Common use of Underwriters’ Warrants Clause in Contracts

Underwriters’ Warrants. The Company hereby agrees to issue to the Representative (and/or its designees) on the applicable Closing Date, warrants, substantially in the form of Exhibit A attached hereto, to purchase such number of Shares equal to four percent (4%) of the Offered Securities sold by the Company (the “Underwriters’ Warrants”). The Underwriters’ Warrants shall be exercisable on a cash or cashless basis, in whole or in part, commencing anytime beginning 180 days after the commencement of the sale of the Firm Shares pursuant to FINRA Rule 5110(e) and expiring on the fifth year anniversary of the commencement of sales of the Firm Shares at an initial exercise price of $[●] per Ordinary Share, which is equal to one hundred and thirty percent (130%) of the initial public offering price per Firm Share. During such time as the Underwriters’ Warrants are outstanding, the Company will agree not to merge, reorganize, or take any action which would terminate the Underwriters’ Warrants without first making adequate provisions for the Underwriters’ Warrants. The Firm Shares, the Additional Shares, and the Underwriters’ Securities are herein referred to collectively as the “Securities.”

Underwriters’ Warrants. The Company hereby agrees to issue to the Representative (and/or its designees) on the applicable Closing Date, warrantsWarrants, substantially in the form of Exhibit A attached hereto, to purchase such number of Shares equal to four five percent (45%) of the Offered Securities sold by the Company (the “Underwriters’ Warrants”). The Underwriters’ Underwriter Warrants shall will be exercisable on a cash or cashless basisexercisable, in whole or in part, commencing anytime beginning 180 days after the commencement six (6) months of the sale of the Firm Shares pursuant to FINRA Rule 5110(e) Closing and expiring will expire on the fifth five-year anniversary of the date of commencement of sales of the Firm Shares Offering at an initial exercise price of $[●] per Ordinary Shareshare of Common Stock, which is equal to one hundred and thirty percent (130100%) of the initial public offering price per of a Firm ShareShare and accompanying Firm Warrant. During such time as the Underwriters’ Warrants are outstanding, the Company will agree not to merge, reorganize, or take any action which would terminate the Underwriters’ Warrants without first making adequate provisions for the Underwriters’ Warrants. The Firm Shares, the Additional Shares, and the Firm Warrants, the Additional Warrants, the Underwriters’ Securities Warrants and the Underlying Shares are herein hereinafter referred to collectively as the “Securities.”

Underwriters’ Warrants. The Company hereby agrees to issue to the Representative (and/or its designees) on the applicable Closing Date, warrantsWarrants, substantially in the form of Exhibit A attached hereto, to purchase such number of Shares equal to four five percent (45%) of the Offered Securities sold by the Company (the “Underwriters’ Warrants”). The Underwriters’ Warrants shall be exercisable on a cash or cashless basis, in whole or in part, commencing anytime beginning 180 days after the commencement of the sale of the Firm Shares pursuant to FINRA Rule 5110(e) from the date of issuance and expiring on the fifth year anniversary of the commencement of sales sale of the Firm Shares Offering at an initial exercise price of $[●] per Ordinary Share, which is equal to one hundred and thirty twenty percent (130120%) of the initial public offering price per of a Firm Share. During such time as the Underwriters’ Warrants are outstanding, the Company will agree not to merge, reorganize, or take any action which would terminate the Underwriters’ Warrants without first making adequate provisions for the Underwriters’ Warrants. The Firm Shares, the Additional Shares, and the Underwriters’ Securities are herein hereinafter referred to collectively as the “Securities.”

Underwriters’ Warrants. The Company hereby agrees to issue to the Representative (and/or its designees) on the applicable Closing Date, warrants, substantially in the form of Exhibit A attached hereto, to purchase such number of Shares equal to four five percent (45%) of the Offered Securities sold by the Company (the “Underwriters’ Warrants”). The Underwriters’ Warrants shall be exercisable on a cash or cashless basis, in whole or in part, commencing anytime beginning 180 days after the commencement of the sale of the Firm Shares pursuant to FINRA Rule 5110(e) and expiring on the fifth year anniversary of the commencement of sales of the Firm Shares at an initial exercise price of $[●] per Ordinary Share, which is equal to one hundred and thirty ten percent (130110%) of the initial public offering price per Firm Share. During such time as the Underwriters’ Warrants are outstanding, the Company will agree not to merge, reorganize, or take any action which would terminate the Underwriters’ Warrants without first making adequate provisions for the Underwriters’ Warrants. The Firm Shares, the Additional Shares, and the Underwriters’ Securities are herein referred to collectively as the “Securities.”

Underwriters’ Warrants. The Company hereby agrees to issue to the Representative (and/or its designees) on the applicable Closing Date, warrantsWarrants, substantially in the form of Exhibit A attached hereto, to purchase such number of Shares equal to four six percent (46%) of the Offered Securities sold by the Company (the “Underwriters’ Warrants”). The Underwriters’ Warrants shall be exercisable on a cash or cashless basis, in whole or in part, commencing anytime beginning 180 days after the commencement of the sale of the Firm Shares pursuant to FINRA Rule 5110(e) from the date of issuance and expiring on the fifth year anniversary of the commencement of sales sale of the Firm Shares Offering at an initial exercise price of $[●] per Ordinary Share, which is equal to one hundred and thirty twenty percent (130120%) of the initial public offering price per of a Firm Share. During such time as the Underwriters’ Warrants are outstanding, the Company will agree not to merge, reorganize, or take any action which would terminate the Underwriters’ Warrants without first making adequate provisions for the Underwriters’ Warrants. The Firm Shares, the Additional Shares, and the Underwriters’ Securities are herein hereinafter referred to collectively as the “Securities.”